| Q91786622 | 3D Cardiac Cell Culture: A Critical Review of Current Technologies and Applications |
| Q89967798 | 3D Co-culture of hiPSC-Derived Cardiomyocytes With Cardiac Fibroblasts Improves Tissue-Like Features of Cardiac Spheroids |
| Q89870333 | 3D bioprinting and its potential impact on cardiac failure treatment: An industry perspective |
| Q91714275 | A Brief Review of Current Maturation Methods for Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes |
| Q90655656 | A Critical Role for Estrogen-Related Receptor Signaling in Cardiac Maturation |
| Q92420779 | A Human iPSC Double-Reporter System Enables Purification of Cardiac Lineage Subpopulations with Distinct Function and Drug Response Profiles |
| Q90117962 | A Novel Fluorescent Reporter System Identifies Laminin-511/521 as Potent Regulators of Cardiomyocyte Maturation |
| Q93024988 | A comprehensive, multiscale framework for evaluation of arrhythmias arising from cell therapy in the whole post-myocardial infarcted heart |
| Q91869836 | A microscale biomimetic platform for generation and electro-mechanical stimulation of 3D cardiac microtissues |
| Q90254927 | A scale model of the human ventricle |
| Q59126221 | A three-dimensional hybrid pacemaker electrode seamlessly integrates into engineered, functional human cardiac tissue in vitro |
| Q90254871 | A tissue-engineered scale model of the heart ventricle |
| Q90250498 | Academic vs industry perspectives in 3D bioprinting |
| Q91695940 | Adult human cardiac stem cell supplementation effectively increases contractile function and maturation in human engineered cardiac tissues |
| Q90408948 | An Unbiased Proteomics Method to Assess the Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes |
| Q90084053 | Assessment of temporal functional changes and miRNA profiling of human iPSC-derived cardiomyocytes |
| Q94544828 | Beyond Family: Modeling Non-hereditary Heart Diseases With Human Pluripotent Stem Cell-Derived Cardiomyocytes |
| Q59336234 | Big bottlenecks in cardiovascular tissue engineering |
| Q64091759 | Bioengineering adult human heart tissue: How close are we? |
| Q92557859 | Biowire Model of Interstitial and Focal Cardiac Fibrosis |
| Q90312976 | CHIR99021 and fibroblast growth factor 1 enhance the regenerative potency of human cardiac muscle patch after myocardial infarction in mice |
| Q91868315 | Cardiac regeneration with pluripotent stem cell-derived cardiomyocytes and direct cardiac reprogramming |
| Q91811749 | Cardiac tissue engineering: state-of-the-art methods and outlook |
| Q89519147 | Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine |
| Q92860231 | Cardiomyogenesis Modeling Using Pluripotent Stem Cells: The Role of Microenvironmental Signaling |
| Q57818505 | Cardiovascular disease models: A game changing paradigm in drug discovery and screening |
| Q61800671 | Cell population balance of cardiovascular spheroids derived from human induced pluripotent stem cells |
| Q98771646 | Cells, Materials, and Fabrication Processes for Cardiac Tissue Engineering |
| Q90621737 | Chronic intermittent tachypacing by an optogenetic approach induces arrhythmia vulnerability in human engineered heart tissue |
| Q90317348 | Circulating re-entrant waves promote maturation of hiPSC-derived cardiomyocytes in self-organized tissue ring |
| Q92712250 | Coculture of Endothelial Cells with Human Pluripotent Stem Cell-Derived Cardiac Progenitors Reveals a Differentiation Stage-Specific Enhancement of Cardiomyocyte Maturation |
| Q94547393 | Comparative Transcriptome Landscape of Mouse and Human Hearts |
| Q101138642 | Comprehensive evaluation of electrophysiological and 3D structural features of human atrial myocardium with insights on atrial fibrillation maintenance mechanisms |
| Q90294713 | Concise Review: Precision Matchmaking: Induced Pluripotent Stem Cells Meet Cardio-Oncology |
| Q57292609 | Concise Review: The Current State of Human in vitro Cardiac Disease Modeling: A Focus on Gene Editing and Tissue Engineering |
| Q90289902 | Considerations for an In Vitro, Cell-Based Testing Platform for Detection of Drug-Induced Inotropic Effects in Early Drug Development. Part 2: Designing and Fabricating Microsystems for Assaying Cardiac Contractility With Physiological Relevance Usi |
| Q97528922 | Contractility of Induced Pluripotent Stem Cell-Cardiomyocytes With an MYH6 Head Domain Variant Associated With Hypoplastic Left Heart Syndrome |
| Q61443553 | Current methods for the maturation of induced pluripotent stem cell-derived cardiomyocytes |
| Q89711257 | DNA damage-free iPS cells exhibit potential to yield competent cardiomyocytes |
| Q91714207 | Decellularized Human Dermal Matrix as a Biological Scaffold for Cardiac Repair and Regeneration |
| Q57808947 | Diabetic Cardiomyopathy Modelling Using Induced Pluripotent Stem Cell Derived Cardiomyocytes: Recent Advances and Emerging Models |
| Q90238907 | Disease modelling and drug discovery for hypertrophic cardiomyopathy using pluripotent stem cells: how far have we come? |
| Q96126759 | Drug response analysis for scaffold-free cardiac constructs fabricated using bio-3D printer |
| Q92811820 | EXPRESS: Right Heart in Pulmonary Hypertension: From Adaptation to Failure |
| Q92969199 | Engineered Macroscale Cardiac Constructs Elicit Human Myocardial Tissue-like Functionality |
| Q92153780 | Engineered Maturation Approaches of Human Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes |
| Q63431936 | Engineering Precision Medicine |
| Q92945485 | Engineering Smart Hybrid Tissues with Built-In Electronics |
| Q89917543 | Engineering anisotropic 3D tubular tissues with flexible thermoresponsive nanofabricated substrates |
| Q90718914 | Engineering hiPSC cardiomyocyte in vitro model systems for functional and structural assessment |
| Q93162829 | Engineering of human cardiac muscle electromechanically matured to an adult-like phenotype |
| Q90404011 | Engineering tissue-specific blood vessels |
| Q90955485 | Enhancement of human iPSC-derived cardiomyocyte maturation by chemical conditioning in a 3D environment |
| Q101403208 | Establishment of a heart-on-a-chip microdevice based on human iPS cells for the evaluation of human heart tissue function |
| Q92846512 | Excision of the expanded GAA repeats corrects cardiomyopathy phenotypes of iPSC-derived Friedreich's ataxia cardiomyocytes |
| Q59829967 | Exercising engineered heart muscle to maturity |
| Q64946783 | Experimental Models of Brugada syndrome. |
| Q93000638 | Extracellular Matrix Structure and Composition in the Early Four-Chambered Embryonic Heart |
| Q58005048 | FOXD1-dependent MICU1 expression regulates mitochondrial activity and cell differentiation |
| Q90352365 | Fatty Acids Enhance the Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells |
| Q92756466 | Force and Calcium Transients Analysis in Human Engineered Heart Tissues Reveals Positive Force-Frequency Relation at Physiological Frequency |
| Q64072324 | Functional Properties of Engineered Heart Slices Incorporating Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
| Q92172438 | GLUT4 expression and glucose transport in human induced pluripotent stem cell-derived cardiomyocytes |
| Q92480289 | Generating ring-shaped engineered heart tissues from ventricular and atrial human pluripotent stem cell-derived cardiomyocytes |
| Q57072496 | Genetic and Tissue Engineering Approaches to Modeling the Mechanics of Human Heart Failure for Drug Discovery |
| Q89870117 | Heart regeneration in mouse and human: A bioengineering perspective |
| Q58705541 | Hierarchical and stage-specific regulation of murine cardiomyocyte maturation by serum response factor |
| Q93025445 | High-Throughput Contractility Assay for Human Stem Cell-Derived Cardiomyocytes |
| Q92978156 | Highly durable crack sensor integrated with silicone rubber cantilever for measuring cardiac contractility |
| Q58554619 | Human Cardiac Organoids for Disease Modeling |
| Q91363886 | Human Cardiac Ventricular-Like Organoid Chambers and Tissue Strips From Pluripotent Stem Cells as a Two-Tiered Assay for Inotropic Responses |
| Q92663895 | Human Induced Pluripotent Stem Cells Derived from a Cardiac Somatic Source: Insights for an In-Vitro Cardiomyocyte Platform |
| Q57473261 | Human Tissue Engineered Model of Myocardial Ischemia-Reperfusion Injury |
| Q58576553 | Human iPS cell-engineered three-dimensional cardiac tissues perfused by capillary networks between host and graft |
| Q98657566 | Human iPSC-Derived Cardiomyocytes Are Susceptible to SARS-CoV-2 Infection |
| Q101226583 | Human perinatal stem cell derived extracellular matrix enables rapid maturation of hiPSC-CM structural and functional phenotypes |
| Q98196692 | Human pluripotent stem cell-derived cardiomyocytes as a target platform for paracrine protection by cardiac mesenchymal stromal cells |
| Q92895912 | Human pluripotent stem cell-derived cardiomyocytes for studying energy metabolism |
| Q55499094 | Human-Induced Pluripotent Stem Cell Technology and Cardiomyocyte Generation: Progress and Clinical Applications. |
| Q99237660 | IP3R-Mediated Compensatory Mechanism for Calcium Handling in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes With Cardiac Ryanodine Receptor Deficiency |
| Q89964079 | Improved Computational Identification of Drug Response Using Optical Measurements of Human Stem Cell Derived Cardiomyocytes in Microphysiological Systems |
| Q92459604 | In vitro analyses of suspected arrhythmogenic thin filament variants as a cause of sudden cardiac death in infants |
| Q91430090 | Induced pluripotent stem cells in disease modelling and drug discovery |
| Q97094347 | Inotropic Assessment in Engineered 3D Cardiac Tissues using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in the BiowireTM II Platform |
| Q90482640 | Intensive care for human hearts in pluripotent stem cell models |
| Q92063866 | Intracellular Reactive Oxygen Species Mediate the Therapeutic Effect of Induced Pluripotent Stem Cells for Acute Kidney Injury |
| Q104289901 | Is zebrafish heart regeneration "complete"? Lineage-restricted cardiomyocytes proliferate to pre-injury numbers but some fail to differentiate in fibrotic hearts |
| Q96343427 | Isogenic models of hypertrophic cardiomyopathy unveil differential phenotypes and mechanism-driven therapeutics |
| Q98238159 | Large-scale spontaneous self-organization and maturation of skeletal muscle tissues on ultra-compliant gelatin hydrogel substrates |
| Q57171613 | Linker of nucleoskeleton and cytoskeleton complex proteins in cardiomyopathy |
| Q64074244 | Long QT Syndrome Modelling with Cardiomyocytes Derived from Human-induced Pluripotent Stem Cells |
| Q60912749 | Long-term functional and structural preservation of precision-cut human myocardium under continuous electromechanical stimulation in vitro |
| Q64075653 | MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo |
| Q89851661 | Maladaptive Contractility of 3D Human Cardiac Microtissues to Mechanical Nonuniformity |
| Q58111146 | Many Cells Make Life Work-Multicellularity in Stem Cell-Based Cardiac Disease Modelling |
| Q91651133 | Maturation of three-dimensional, hiPSC-derived cardiomyocyte spheroids utilizing cyclic, uniaxial stretch and electrical stimulation |
| Q90683736 | Mending a broken heart: current strategies and limitations of cell-based therapy |
| Q90640179 | MiR-499 Responsive Lethal Construct for Removal of Human Embryonic Stem Cells after Cardiac Differentiation |
| Q64234683 | Modeling cardiac complexity: Advancements in myocardial models and analytical techniques for physiological investigation and therapeutic development |
| Q58561894 | Models of Ischemia-Reperfusion Injury |
| Q91557750 | Molecular mechanisms of arrhythmogenic cardiomyopathy |
| Q92922799 | Multi-cellularity in cardiac tissue engineering, how close are we to native heart tissue? |
| Q64060127 | Optical Recording of Action Potentials in Human Induced Pluripotent Stem Cell-Derived Cardiac Single Cells and Monolayers Generated from Long QT Syndrome Type 1 Patients |
| Q64038731 | Optimizing Blended Collagen-Fibrin Hydrogels for Cardiac Tissue Engineering with Human iPSC-derived Cardiomyocytes |
| Q93000650 | Organ-on-e-chip: Three-dimensional self-rolled biosensor array for electrical interrogations of human electrogenic spheroids |
| Q99350419 | Organs-on-chips: into the next decade |
| Q94445507 | PGC-1α activator ZLN005 promotes maturation of cardiomyocytes derived from human embryonic stem cells |
| Q92217698 | Patient and Disease-Specific Induced Pluripotent Stem Cells for Discovery of Personalized Cardiovascular Drugs and Therapeutics |
| Q60303926 | Perspectives on the Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Biomedical Research |
| Q92994217 | Phenotypic Variation Between Stromal Cells Differentially Impacts Engineered Cardiac Tissue Function |
| Q92519813 | Polyethylene Terephthalate Textiles Enhance the Structural Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
| Q90619103 | Polyunsaturated fatty acid analogues differentially affect cardiac Nav, Cav, and Kv channels through unique mechanisms |
| Q89049041 | Progress, obstacles, and limitations in the use of stem cells in organ-on-a-chip models |
| Q64105537 | Qualitative transcriptional signatures for evaluating the maturity degree of pluripotent stem cell-derived cardiomyocytes |
| Q90670805 | Regulation of cardiomyocyte maturation during critical perinatal window |
| Q99630286 | Retinoic acid promotes metabolic maturation of human Embryonic Stem Cell-derived Cardiomyocytes |
| Q64117405 | SarcTrack |
| Q99589742 | Simple Workflow and Comparison of Media for hPSC-Cardiomyocyte Cryopreservation and Recovery |
| Q95661032 | Single-cell analysis of murine fibroblasts identifies neonatal to adult switching that regulates cardiomyocyte maturation |
| Q57823790 | Strategies for Improving the Maturity of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
| Q91975109 | Targeting HIF-1α in combination with PPARα activation and postnatal factors promotes the metabolic maturation of human induced pluripotent stem cell-derived cardiomyocytes |
| Q92815378 | The Emergence of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) as a Platform to Model Arrhythmogenic Diseases |
| Q64080614 | Three-dimensional microengineered models of human cardiac diseases |
| Q96304765 | Toward Cardiac Regeneration: Combination of Pluripotent Stem Cell-Based Therapies and Bioengineering Strategies |
| Q90215595 | Training heart tissue to mature |
| Q93024453 | Transcriptomic analysis of 3D Cardiac Differentiation of Human Induced Pluripotent Stem Cells Reveals Faster Cardiomyocyte Maturation Compared to 2D Culture |
| Q90165282 | Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Preclinical Cancer Drug Cardiotoxicity Testing: A Scientific Statement From the American Heart Association |
| Q64285907 | User-Friendly and Parallelized Generation of Human Induced Pluripotent Stem Cell-Derived Microtissues in a Centrifugal Heart-on-a-Chip |
| Q91991760 | Voltage Imaging of Cardiac Cells and Tissue Using the Genetically Encoded Voltage Sensor Archon1 |
| Q97526629 | When Stiffness Matters: Mechanosensing in Heart Development and Disease |